JP2007500229A5 - - Google Patents

Download PDF

Info

Publication number
JP2007500229A5
JP2007500229A5 JP2006533343A JP2006533343A JP2007500229A5 JP 2007500229 A5 JP2007500229 A5 JP 2007500229A5 JP 2006533343 A JP2006533343 A JP 2006533343A JP 2006533343 A JP2006533343 A JP 2006533343A JP 2007500229 A5 JP2007500229 A5 JP 2007500229A5
Authority
JP
Japan
Prior art keywords
composition according
medicinal composition
independently
formulated
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006533343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007500229A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/016235 external-priority patent/WO2005007080A2/en
Publication of JP2007500229A publication Critical patent/JP2007500229A/ja
Publication of JP2007500229A5 publication Critical patent/JP2007500229A5/ja
Pending legal-status Critical Current

Links

JP2006533343A 2003-05-20 2004-05-20 腫瘍の治療のためのカテコールブタンの投与のための方法と組成物 Pending JP2007500229A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US47200803P 2003-05-20 2003-05-20
US47228203P 2003-05-20 2003-05-20
US47214403P 2003-05-20 2003-05-20
US47218803P 2003-05-20 2003-05-20
US47229903P 2003-05-20 2003-05-20
PCT/US2004/016235 WO2005007080A2 (en) 2003-05-20 2004-05-20 Methods and compositions for delivery of catecholic butanes for treatment of tumors

Publications (2)

Publication Number Publication Date
JP2007500229A JP2007500229A (ja) 2007-01-11
JP2007500229A5 true JP2007500229A5 (https=) 2007-07-05

Family

ID=33545640

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006533316A Pending JP2006528701A (ja) 2003-05-20 2004-05-20 疾患の治療のためのカテコールブタンの投与のための方法と組成物
JP2006533343A Pending JP2007500229A (ja) 2003-05-20 2004-05-20 腫瘍の治療のためのカテコールブタンの投与のための方法と組成物
JP2006533314A Pending JP2006528700A (ja) 2003-05-20 2004-05-20 肥満の治療のためのカテコールブタンの投与のための方法と組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006533316A Pending JP2006528701A (ja) 2003-05-20 2004-05-20 疾患の治療のためのカテコールブタンの投与のための方法と組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2006533314A Pending JP2006528700A (ja) 2003-05-20 2004-05-20 肥満の治療のためのカテコールブタンの投与のための方法と組成物

Country Status (6)

Country Link
US (1) US20060141047A1 (https=)
EP (3) EP1631269A4 (https=)
JP (3) JP2006528701A (https=)
CN (1) CN103585136A (https=)
AU (3) AU2004249123A1 (https=)
WO (3) WO2005007080A2 (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10214983A1 (de) 2002-04-04 2004-04-08 TransMIT Gesellschaft für Technologietransfer mbH Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
AU2003253214A1 (en) * 2002-09-09 2004-03-29 Koninklijke Philips Electronics N.V. Method of signal reconstruction, imaging device and computer program product
WO2006079021A2 (en) * 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Use of sirtuin-activating compounds for treating flushing and drug induced weight gain
CA2595606C (en) * 2005-01-27 2014-12-16 Erimos Pharmaceuticals Llc Oral formulations for delivery of catecholic butanes including ndga compounds
CN101325944B (zh) * 2005-10-11 2013-01-16 耶路撒冷希伯来大学伊萨姆研究开发公司 用于鼻部给药的组合物
US20070128289A1 (en) * 2005-12-07 2007-06-07 Zhao Jonathon Z Nano-and/or micro-particulate formulations for local injection-based treatment of vascular diseases
FR2896694A1 (fr) 2006-01-30 2007-08-03 Genfit S A Utilisation d'inhibiteurs de 15-lipoxygenases dans le traitement du syndrome metabolique
US7863157B2 (en) * 2006-03-17 2011-01-04 Silicon Genesis Corporation Method and structure for fabricating solar cells using a layer transfer process
DE102006013531A1 (de) * 2006-03-24 2007-09-27 Lts Lohmann Therapie-Systeme Ag Polylactid-Nanopartikel
GB2441499B (en) * 2006-09-08 2011-09-14 Jasin El Sammadoni Slimming Spray
US9067875B2 (en) 2006-10-02 2015-06-30 Erimos Pharmaceuticals Llc Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
EP2076252B1 (en) 2006-10-02 2014-04-02 Erimos Pharmaceuticals LLC Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
EP1970051A1 (en) * 2007-03-14 2008-09-17 Merz Pharma GmbH & Co.KGaA Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases
EP2039352A1 (en) * 2007-09-18 2009-03-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules
US8962015B2 (en) 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
US9145453B2 (en) * 2007-09-28 2015-09-29 Sdg, Inc. Orally bioavailable lipid-based constructs
US8846053B2 (en) * 2008-09-26 2014-09-30 Sdg, Inc. Orally bioavailable lipid-based constructs
US20100080773A1 (en) 2008-09-26 2010-04-01 Sdg, Inc. Orally Bioavailable Lipid-Based Constructs
US9161943B2 (en) 2007-12-31 2015-10-20 Industrial Technology Research Institute Sustained release composition and manufacturing method thereof
US20100093872A1 (en) * 2008-10-15 2010-04-15 Erimos Pharmaceuticals Llc Stable aqueous formulations of water insoluble or poorly soluble drugs
WO2010102065A1 (en) 2009-03-05 2010-09-10 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives
WO2010111132A2 (en) 2009-03-27 2010-09-30 Bend Research, Inc. Spray-drying process
DE102009031274A1 (de) 2009-06-30 2011-01-13 Justus-Liebig-Universität Giessen Liposomen zur pulmonalen Applikation
EP2538929A4 (en) 2010-02-25 2014-07-09 Univ Johns Hopkins DELAYED RELEASE OF THERAPIES IN A PART OF THE EYE
US9084976B2 (en) 2010-09-03 2015-07-21 Bend Research, Inc. Spray-drying apparatus and methods of using the same
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
JP5222917B2 (ja) * 2010-09-21 2013-06-26 財團法人工業技術研究院 徐放性組成物およびその製造方法
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
WO2012109363A2 (en) 2011-02-08 2012-08-16 The Johns Hopkins University Mucus penetrating gene carriers
US9084727B2 (en) 2011-05-10 2015-07-21 Bend Research, Inc. Methods and compositions for maintaining active agents in intra-articular spaces
US20140329913A1 (en) * 2011-12-14 2014-11-06 The Johns Hopkins University Nanoparticles with enhanced mucosal penetration or decreased inflammation
JP6255038B2 (ja) * 2013-02-26 2017-12-27 トリアクト セラピューティクス，インク． 癌治療
WO2015175545A1 (en) 2014-05-12 2015-11-19 The Johns Hopkins University Highly stable biodegradable gene vector platforms for overcoming biological barriers
JP6953414B2 (ja) * 2016-01-20 2021-10-27 フラリー パウダーズ エルエルシーＦｌｕｒｒｙ Ｐｏｗｄｅｒｓ，Ｌｌｃ 親油性成分を含む吸入に好適な分散性の噴霧乾燥粉末を製造する方法
WO2018169954A1 (en) 2017-03-13 2018-09-20 Sdg, Inc. Lipid-based nanoparticles with enhanced stability
US11077173B2 (en) 2017-03-13 2021-08-03 Sdg, Inc. Lipid-based nanoparticles and methods using same
US12496279B2 (en) 2019-04-11 2025-12-16 The Johns Hopkins University Nanoparticles for drug delivery to brain
CN114831938B (zh) * 2022-05-24 2023-04-18 郑州大学第一附属医院 一种包载阿托伐他汀钙的聚合物胶束、制剂及制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3934034A (en) * 1972-08-21 1976-01-20 Sandoz, Inc. Hydroxy substituted diphenylalkyls for treatment of lipidemia
US4098908A (en) * 1975-10-20 1978-07-04 Sandoz, Inc. Phenoxyphenyl pyridyl ketones and derivatives and their use as hypolepidemic agents
US5008294A (en) * 1985-02-11 1991-04-16 Chemex Pharmaceuticals, Inc. Methods of treating tumors with compositions of catecholic butanes
US4774229A (en) * 1982-04-05 1988-09-27 Chemex Pharmaceuticals, Inc. Modification of plant extracts from zygophyllaceae and pharmaceutical use therefor
US4708964A (en) * 1984-02-09 1987-11-24 Chemex Pharmaceuticals Lipoxygenase inhibitors
GB8416234D0 (en) * 1984-06-26 1984-08-01 Ici Plc Biodegradable amphipathic copolymers
US4880637A (en) * 1985-02-11 1989-11-14 Chemex Pharmaceuticals, Inc. Compositions of catecholic butanes with zinc
WO1988003800A1 (en) * 1986-11-19 1988-06-02 Chemex Pharmaceuticals, Inc. Lipoxygenase inhibitors
WO1995005156A1 (en) * 1993-08-17 1995-02-23 Schering-Plough Healthcare Products, Inc. Compositions for treating corns, calluses and warts
US6365787B1 (en) * 1994-09-30 2002-04-02 The Johns Hopkins University Compounds for the suppression of HIV TAT transactivation
AU698619B2 (en) * 1995-06-07 1998-11-05 University Of Southern California Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors
US5837252A (en) * 1996-07-01 1998-11-17 Larreacorp, Ltd. Nontoxic extract of Larrea tridentata and method of making same
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
AU8759298A (en) * 1997-10-06 1999-04-27 Shaman Pharmaceuticals, Inc. Use of nordihydroguaiaretic acid to lower serum triglycerides, blood pressure and to treat syndrome
US6576660B1 (en) * 1997-10-31 2003-06-10 Arch Development Corporation Methods and compositions for regulation of 5-α-reductase activity
US6214874B1 (en) * 1999-10-15 2001-04-10 John Hopkins University Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N
US6608108B2 (en) * 1999-10-15 2003-08-19 Johns Hopkins University Method for treatment of tumors using nordihydroguaiaretic acid derivatives
US6545019B2 (en) * 2000-07-13 2003-04-08 Bristol-Myers Squibb Company Method of modulating microglial activation for the treatment of acute and chronic neurodegenerative disorders
US7365099B2 (en) * 2001-05-31 2008-04-29 Wisconsin Alumni Research Foundation Animal body fat control
SK287806B6 (sk) * 2001-06-28 2011-10-04 Pfizer Products Inc. Triamid-substituované indoly, benzofurány a benzotiofény ako inhibítory mikrozómového proteínu prenášajúceho triglyceridu (MTP) a/alebo sekrécie apolipoproteínu B (Apo B)
WO2003103583A2 (en) * 2002-06-10 2003-12-18 Oklahoma Medical Research Foundation A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system

Similar Documents

Publication Publication Date Title
JP2007500229A5 (https=)
JP2006528701A5 (https=)
JP5027885B2 (ja) 水難溶性カンプトテシン誘導体のサブミクロンナノ粒子及びその製造方法
JP2006528700A5 (https=)
EP2952184B1 (en) Pharmaceutical formulation for treating pancreatic cancer
US20150064283A1 (en) Pharmaceutical compositions for parenteral administration
KR20230118632A (ko) 암을 치료하기 위한 물질 및 방법
CN108366975A (zh) 使用脱氧胆酸和其盐对堆积的脂肪的治疗
AU2008331500B2 (en) Intravesical compositions with valrubicin for the treatment of bladder cancer
EP4157290A1 (en) Compositions, their uses in therapy and methods thereof
EP4349325A1 (en) Use of mitoxantrone hydrochloride liposome in preparation of drugs for treating advanced solid tumors
ES2696823T3 (es) Uso de icaritina para la preparación de una composición para el tratamiento de cáncer
JP6498610B2 (ja) カバジタキセル組成物
RU2010129038A (ru) Соединения, предназначенные для лечения рака
JP2015529196A (ja) ラサギリンの非経口製剤
KR20150126595A (ko) 간 질환 또는 증상의 치료를 위한 용도 및 방법
JP6480467B2 (ja) 疎水性薬物送達のための新規なポリマーベースのヒドロトロープ
JP2025011312A (ja) ｐ－ボロノフェニルアラニンを含有する注射液剤の析出防止方法
JP2020182486A5 (https=)
JP2000507207A (ja) 複合注射剤
EA004570B1 (ru) Применение производного антрациклина для лечения опухоли печени
JP4020256B2 (ja) 前立腺癌の局所治療剤
JPWO2021048817A5 (https=)
KR20230149007A (ko) 생리활성물질 전달체
US20160129117A1 (en) Novel Boronic Acid Compound Preparation